These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 2504834

  • 41. Comparative efficacy of 5 days of dirithromycin and 7 days of erythromycin in skin and soft tissue infections.
    Wasilewski MM, Wilson MG, Sides GD, Stotka JL.
    J Antimicrob Chemother; 2000 Aug; 46(2):255-62. PubMed ID: 10933649
    [Abstract] [Full Text] [Related]

  • 42. A multicenter comparative study of cefotetan once daily and cefoxitin thrice daily for the treatment of infections of the skin and superficial soft tissue.
    Geckler RW, Eng RH, Fabian TC, Echols RM, Jemsek JG, LeFrock JL, Mogabgab WC, Wilson SE.
    Am J Surg; 1988 May 31; 155(5A):91-5. PubMed ID: 3287976
    [Abstract] [Full Text] [Related]

  • 43. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen.
    Bradsher RW, Snow RM.
    Am J Med; 1984 Oct 19; 77(4C):63-7. PubMed ID: 6093522
    [Abstract] [Full Text] [Related]

  • 44. Comparative efficacy and toxicity of roxithromycin and erythromycin ethylsuccinate in the treatment of streptococcal pharyngitis in adults.
    Melcher GP, Hadfield TL, Gaines JK, Winn RE.
    J Antimicrob Chemother; 1988 Oct 19; 22(4):549-56. PubMed ID: 3060461
    [Abstract] [Full Text] [Related]

  • 45. Comparative double-blinded study between mupirocin and tetracycline ointments for treating skin infections.
    Wong KS, Lim KB, Tham SN, Ling ML, Tan T.
    Singapore Med J; 1989 Aug 19; 30(4):380-3. PubMed ID: 2510312
    [Abstract] [Full Text] [Related]

  • 46. Cefadroxil in the treatment of skin and soft tissue infections.
    Ballantyne F.
    J Antimicrob Chemother; 1982 Sep 19; 10 Suppl B():143-7. PubMed ID: 6754687
    [No Abstract] [Full Text] [Related]

  • 47. Systemic antimicrobial therapy in skin and skin structure infections: comparison of temafloxacin and ciprofloxacin.
    Parish LC, Jungkind DL.
    Am J Med; 1991 Dec 30; 91(6A):115S-119S. PubMed ID: 1662880
    [Abstract] [Full Text] [Related]

  • 48. [Clinical evaluation of S6472 (prolonged action preparation of cefaclor) in the treatment of skin and soft tissue infections. A double blind comparison of S6472 and cefaclor].
    Sakai K, Fujimoto M, Ueda T, Yura J, Shinagawa N, Ishikawa S, Tachi Y, Kobe A, Shibata Y, Doi S.
    Jpn J Antibiot; 1985 Oct 30; 38(10):2716-34. PubMed ID: 3908726
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Ciprofloxacin versus cefotaxime in skin and skin structure infections: a double-blind study.
    Ramirez-Ronda C, Saavedra S.
    Chemioterapia; 1987 Jun 30; 6(2 Suppl):432-4. PubMed ID: 3334591
    [No Abstract] [Full Text] [Related]

  • 52. Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.
    Young RA, Gonzalez JP, Sorkin EM.
    Drugs; 1989 Jan 30; 37(1):8-41. PubMed ID: 2651088
    [Abstract] [Full Text] [Related]

  • 53. [Josamycin in bronchopulmonary and otorhinological diseases in pediatrics].
    Kerschbaum H, Moritz AJ.
    Padiatr Padol; 1983 Jan 30; 18(4):403-8. PubMed ID: 6646791
    [Abstract] [Full Text] [Related]

  • 54. [Comparison of 3 antibiotics, cefaclor, josamycin and penicillin V in the treatment of acute throat infections. A multicenter study: 581 cases].
    Elbaz P, Salord JC.
    Pathol Biol (Paris); 1987 Jun 30; 35(5 Pt 2):847-52. PubMed ID: 3309827
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and/or soft tissue infections.
    Montero L.
    J Antimicrob Chemother; 1996 Jun 30; 37 Suppl C():125-31. PubMed ID: 8818853
    [Abstract] [Full Text] [Related]

  • 57. In vitro and in vivo antibacterial activity of 9,3"-Di-o-acetyl midecamycin (Mom), a new macrolide antibiotic.
    Kawaharajo K, Sekizawa Y, Inoue M.
    J Antibiot (Tokyo); 1981 Apr 30; 34(4):436-42. PubMed ID: 6974163
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Comparative study of TMS-19-Q and midecamycin for respiratory tract infection by double-blind method].
    Kobayashi H, Nihei T, Takeda H, Kohno K, Saito A, Tomizawa M, Nakayama I, Hiraga Y, Kikuchi K, Yamamoto A.
    Kansenshogaku Zasshi; 1985 Feb 30; 59(2):201-26. PubMed ID: 3925037
    [No Abstract] [Full Text] [Related]

  • 60. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
    McCarty J, Ruoff GE, Jacobson KD.
    Am J Med; 1992 Jun 22; 92(6A):80S-85S. PubMed ID: 1621751
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.